Moderna pauses efforts to build vaccine plant in Kenya, FT says

Modern has put plans to build a vaccine plant in Kenya on hold, a sign its move to invest in pandemic preparedness in Africa has dropped the agenda as COVID-19 sales decline, Oliver Barnes, Andres Schipani, and Michael Peel of The Financial Times says. A year ago, Modern made a deal with the Kenyan government to invest $200M in a facility that would produce up to 500M vaccine shots a year. It has yet to buy a plot earmarked for it in a special economic zone near Nairobi, two people familiar with the matter said. In a recent statement to the Financial Times, the company confirmed it had “paused its efforts.”